Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Intangible Assets
Tibet Rhodiola Pharmaceutical Holding Co
Intangible Assets Peer Comparison
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Intangible Assets
¥203.8m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
18%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Intangible Assets
¥10.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Intangible Assets
¥6.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Intangible Assets
¥2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Intangible Assets
¥386.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
19%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Intangible Assets
¥3.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Intangible Assets?
Intangible Assets
203.8m
CNY
Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Intangible Assets amounts to 203.8m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
18%
Over the last year, the Intangible Assets growth was -50%. The average annual Intangible Assets growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been -40% over the past three years , -29% over the past five years , and 18% over the past ten years .